1. FDA Guidance for industry: diabetes mellitus-evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes Maryland 2008
2. Design and analysis of non-inferiority mortality trials in oncology;Rothmann;Statistics in Medicine,2003
3. Monitoring a clinical trial with multiple hypotheses concerning the treatment effect on a single primary endpoint;Denne;Statistics in Medicine,2001
4. Parks MH Clinical Perspectives on FDA Guidance for Industry: Diabetes Mellitus - Evaluating CV Risk in New Anti-diabetic Therapies to Treat T2DM 2009 www.fda.gov/downloads/Drugs/NewsEvents/UCM209087.pdf